Chad Messer | VP, IR, Strategic Finance |
Florian Brand | CEO |
Srinivas Rao | Co-Founder & Chief Scientific Officer |
Greg Weaver | CFO |
Charles Duncan | Cantor Fitzgerald |
Neena Bitritto-Garg | Citi |
Ritu Baral | Cowen & Company |
Judah Frommer | Credit Suisse |
Andrew Tsai | Jefferies |
Esther Hong | Berenberg |
Brian Abrahams | RBC Capital Markets |
Elemer Piros | ROTH Capital Partners |
Sumant Kulkarni | Canaccord Genuity |
Nathan Weinstein | Aegis Capital |
Good morning. And welcome the ATAI Life Sciences Third Quarter 2021 Financial Results and Corporate Update Conference Call. Currently all participants are in listen-only mode. This call is being webcast live via the News & Events section of the company's website at www.atai.life and is being recorded.
For opening remarks I would like to introduce Chad Messer, Vice President of Investor Relations and Strategic Finance of ATAI Life Sciences.